Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$67.2K Sell
10,960
-832
-7% -$5.26K 0.17% 186
2025
Q2
$76.4K Buy
+11,792
New +$63.5K 0.09% 321
2024
Q4
Sell
-29,680
Closed -$234K 630
2024
Q3
$234K Buy
29,680
+9,136
+44% +$82.2K 0.11% 299
2024
Q2
$212K Buy
+20,544
New +$223K 0.11% 340
2022
Q2
Sell
-7,968
Closed -$230K 505
2022
Q1
$230K Sell
7,968
-5,692
-42% -$156K 0.1% 321
2021
Q4
$378K Buy
+13,660
New +$386K 0.17% 126

Other funds holding TBI

Corton Capital's TBI Position: Q3 2025 in Review

Corton Capital reduced its Trueblue (TBI) stake by 7.1% in Q3 2025, selling an estimated $5.26K and leaving 10,960 shares worth $67.2K. The position accounts for 0.17% of the portfolio, ranked #186.

Corton Capital first reported a position in TBI in Q4 2021 and has held it in 6 quarters since. The position peaked at $378K in Q4 2021. 108 funds tracked by Wall St. Rank hold TBI as of Q3 2025.

  • Corton Capital held 10,960 shares of Trueblue worth $67.2K as of Q3 2025.
  • Corton Capital sold 832 Trueblue shares in Q3 2025, an estimated $5.26K.
  • Trueblue made up 0.17% of Corton Capital's portfolio in Q3 2025, its #186 holding.
  • Corton Capital first reported a position in Trueblue in Q4 2021 and has held it in 6 quarters since.
  • Corton Capital's Trueblue position peaked at $378K in Q4 2021.
  • 108 funds tracked by Wall St. Rank held Trueblue as of Q3 2025.

Based on Corton Capital's 13F filing for Q3 2025, filed 14 Nov 2025.